10,959 Shares in Doximity, Inc. (NASDAQ:DOCS) Acquired by WINTON GROUP Ltd

WINTON GROUP Ltd acquired a new position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 10,959 shares of the company's stock, valued at approximately $585,000.

A number of other hedge funds have also recently added to or reduced their stakes in DOCS. Vanguard Group Inc. boosted its stake in Doximity by 4.5% during the 4th quarter. Vanguard Group Inc. now owns 11,203,569 shares of the company's stock valued at $598,159,000 after purchasing an additional 485,102 shares during the last quarter. LPL Financial LLC raised its stake in Doximity by 5.5% in the 4th quarter. LPL Financial LLC now owns 75,757 shares of the company's stock valued at $4,045,000 after acquiring an additional 3,967 shares during the period. Optimum Investment Advisors bought a new stake in Doximity during the 4th quarter valued at $43,000. KLP Kapitalforvaltning AS bought a new stake in shares of Doximity during the 4th quarter valued at $2,258,000. Finally, AXQ Capital LP bought a new stake in shares of Doximity during the fourth quarter valued at about $863,000. Institutional investors and hedge funds own 87.19% of the company's stock.

Doximity Stock Down 7.0 %

Shares of NASDAQ:DOCS traded down $4.05 on Thursday, hitting $53.90. 682,360 shares of the company traded hands, compared to its average volume of 1,936,256. The company has a market cap of $10.06 billion, a PE ratio of 53.90, a PEG ratio of 4.10 and a beta of 1.34. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $85.21. The stock has a 50 day simple moving average of $65.63 and a 200-day simple moving average of $54.84.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on DOCS shares. Stephens began coverage on shares of Doximity in a report on Friday, December 20th. They issued an "equal weight" rating and a $55.00 price target on the stock. Leerink Partnrs upgraded Doximity from a "hold" rating to a "strong-buy" rating in a research report on Friday, February 7th. Leerink Partners upgraded shares of Doximity from a "market perform" rating to an "outperform" rating and upped their price target for the company from $60.00 to $90.00 in a research report on Friday, February 7th. Raymond James reaffirmed an "outperform" rating and issued a $83.00 target price (up from $65.00) on shares of Doximity in a research note on Friday, February 7th. Finally, Bank of America boosted their price target on Doximity from $54.00 to $57.00 and gave the company a "neutral" rating in a report on Monday, January 6th. Eleven equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $64.22.

Insiders Place Their Bets

In related news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the sale, the director now directly owns 6,360 shares of the company's stock, valued at $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 37.40% of the company's stock.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.